GH Research PLC

Company Profile

GH Research PLC had its IPO on 2021-06-25 under the ticker symbol GHRS.

The company operates in the Healthcare sector and Biotechnology industry. GH Research PLC has a staff strength of 32 employees.

Stock update

Shares of GH Research PLC opened at $10.13 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $10.01 - $10.29, and closed at $10.26.

This is a +2.6% increase from the previous day's closing price.

A total volume of 10,139 shares were traded at the close of the day’s session.

In the last one week, shares of GH Research PLC have slipped by -1.54%.

GH Research PLC's Key Ratios

GH Research PLC has a market cap of $542.06 million, indicating a price to book ratio of 2.1985 and a price to sales ratio of 0.

In the last 12-months GH Research PLC’s revenue was $0 with a gross profit of $0 and an EBITDA of $-36067000. The EBITDA ratio measures GH Research PLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, GH Research PLC’s operating margin was 0% while its return on assets stood at -8.91% with a return of equity of -14.39%.

In Q2, GH Research PLC’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

GH Research PLC’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.69 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into GH Research PLC’s profitability.

GH Research PLC stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -31.0029. Its price to sales ratio in the trailing 12-months stood at 0.

GH Research PLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$240.27 million

Total Liabilities

$6.56 million

Operating Cash Flow

$0

Capital Expenditure

$46000

Dividend Payout Ratio

0%

GH Research PLC ended 2024 with $240.27 million in total assets and $0 in total liabilities. Its intangible assets were valued at $240.27 million while shareholder equity stood at $232.98 million.

GH Research PLC ended 2024 with $0 in deferred long-term liabilities, $6.56 million in other current liabilities, 1301000.00 in common stock, $-51159000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $96.90 million and cash and short-term investments were $165.38 million. The company’s total short-term debt was $267,000 while long-term debt stood at $0.

GH Research PLC’s total current assets stands at $166.40 million while long-term investments were $72.70 million and short-term investments were $68.49 million. Its net receivables were $0 compared to accounts payable of $2.91 million and inventory worth $0.

In 2024, GH Research PLC's operating cash flow was $0 while its capital expenditure stood at $46000.

Comparatively, GH Research PLC paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$10.26

52-Week High

$14.64

52-Week Low

$5.7

Analyst Target Price

$37.4

GH Research PLC stock is currently trading at $10.26 per share. It touched a 52-week high of $14.64 and a 52-week low of $14.64. Analysts tracking the stock have a 12-month average target price of $37.4.

Its 50-day moving average was $11.89 and 200-day moving average was $10.38 The short ratio stood at 11.91 indicating a short percent outstanding of 0%.

Around 4039.2% of the company’s stock are held by insiders while 5806.3% are held by institutions.